Form 4 for AMGN Amgen
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001127602-25-006112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-20 | 2025-02-18+ | AMGN | Miller Derek | SVP, Human Resources | S - Sale+OE | $293.45 | -2,024 | 8,544 | -19% | -$593.9K |
| D | 2025-02-20 | 2025-02-19 | AMGN | Miller Derek | SVP, Human Resources | M - OptEx | $156.35 | +1,524 | 10.1K | +18% | +$238.3K |
| D | 2025-02-20 | 2025-02-19 | AMGN | Miller Derek | SVP, Human Resources | M - OptEx | $0.00 | -1,524 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | S | D | 500 | $292.56 | 8,544 | D | — | — | (F1) The price reported is an average price. The prices ranged from $289.00 to $293.33 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| 2 | Common | Common Stock | 2025-02-19 | S | D | 1,524 | $293.74 | 8,544 | D | — | — | (F3) The price reported is an average price. The prices ranged from $291.90 to $295.97 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer. (F4) These shares include 153 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| 3 | Common | Common Stock | 2025-02-19 | M | A | 1,524 | $156.35 | 10,068 | D | — | — | (F2) These shares were acquired in connection with the exercise of stock options expiring on May 3, 2026. |
| 4 | Derivative | Nqso (Right to Buy) | 2025-02-19 | M | D | 1,524 | $0.00 | 0 | D | $156.35 · 2018-05-03 to 2026-05-03 | 1,524 Common Stock |